| 000 | 00874 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516190608.0 | ||
| 264 | 0 | _c20140224 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1555-7162 | ||
| 024 | 7 |
_a10.1016/j.amjmed.2013.10.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Meng-Ting | |
| 245 | 0 | 0 |
_aThe reply. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cJan 2014 |
||
| 300 |
_ae9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 700 | 1 | _aChu, Che-Li | |
| 773 | 0 |
_tThe American journal of medicine _gvol. 127 _gno. 1 _gp. e9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjmed.2013.10.006 _zAvailable from publisher's website |
| 999 |
_c23411007 _d23411007 |
||